Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

DIRECTOR DEALINGS: Advanced Oncotherapy Exec Chair Ups Stake To 2.7%

19th Aug 2020 06:12

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Executive Chair Michael Sinclair buys 145,000 shares at average 32.18 pence, worth GBP46,661, on Monday and Tuesday. Now has 8.3 million shares, a 2.7% stake.

Current stock price: 34.00p

Year-to-date change: down 15%

By Tom Waite; [email protected]

Copyright 2020 Alliance News Limited. All Rights Reserved.


Related Shares:

AVO.L
FTSE 100 Latest
Value8,758.04
Change-16.61